The FDA allows for charging for investigational products used in clinical research under certain circumstances. The federal regulations also state that participants should be informed of any additional costs that may result from participation in research. Recent “research studies” are using this guidance as a loophole to charge participants for studies that may not create generalizable knowledge. Ms. Oeser will review the ethical issues involved in recent pay-to-participate “research studies” and how these may violate the pillars of respect of persons, beneficence, and justice.
This is a 32 minute internet media player video of a voice over slide show.
A quiz concluding the presentation will summarize the topic and evaluate your understanding of the material.
At the completion of the webinar, participants should be able to:
Speaker:
Annette has worked in clinical research for the past 29 years, primarily in PI initiated studies. She currently works as a Clinical/Translational Research Coordinator III in the Division of Clinical Pharmacology at Vanderbilt University Medical Center. She was certified CCRP in 2004 and has been a member of the Greater Nashville Region SoCRA chapter’s Education Committee since 2007. She obtained her Master of Liberal Arts and Sciences (MLAS) degree from Vanderbilt University in 2011, and completed level 1 of the Vanderbilt Program in Research Administration Development (VPRAD) in 2012.
Members - Free
Non-Members - $75.00 (includes 1 year membership)
If you are not a current member, you will be asked to create an account to view the online training.
SOCRA designates this educational activity for a maximum of 0.75 Continuing Education Credits for SOCRA CE.
Termination Date: 12/22/2026
ADVANCING INNOVATION AND INTEGRITY:
A TIME FOR TRANSFORMATION IN CLINICAL RESEARCH
8 tracks I 20+ Topic Areas I 100+ Sessions I 70+CE